|
Volumn 19, Issue 15, 2011, Pages 4562-4573
|
Synthesis and antimalarial activity of new heterocyclic hybrids based on chloroquine and thiazolidinone scaffolds
|
Author keywords
Antimalarial activity; Chloroquine; Heterocyclic hybrids; Synthesis; Thiazolidin 4 ones
|
Indexed keywords
2 [3,4 (METHYLENDIOXY)PHENYL] 3 [2 [(7 CHLOROQUINOLIN 4 YL)AMINO]ETHYL]THIAZOLIDIN 4 ONE;
3 [2 (7 CHLOROQUINOLIN 4 YLAMINO)ETHYL] 2 (3,4 DIMETHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [2 (7 CHLOROQUINOLIN 4 YLAMINO)ETHYL] 2 (3,4,5 TRIMETHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [2 (7 CHLOROQUINOLIN 4 YLAMINO)ETHYL] 2 (FURAN 2 YL)THIAZOLIDIN 4 ONE;
3 [2 (7 CHLOROQUINOLIN 4 YLAMINO)ETHYL] 2 (THIOPHEN 2 YL)THIAZOLIDIN 4 ONE;
3 [2 [(7 CHLOROQUINOLIN 4 YL)AMINO]ETHYL] 2 (3 HYDROXY 4 METHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [2 [(7 CHLOROQUINOLIN 4 YL)AMINO]ETHYL] 2 (4 HYDROXY 3 METHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [2 [(7 CHLOROQUINOLIN 4 YL)AMINO]ETHYL] 2 PHENYLTHIAZOLIDIN 4 ONE;
3 [3 (7 CHLOROQUINOLIN 4 YLAMINO)PROPYL] 2 (3,4 DIMETHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [3 (7 CHLOROQUINOLIN 4 YLAMINO)PROPYL] 2 (FURAN 2 YL)THIAZOLIDIN 4 ONE;
3 [3 (7 CHLOROQUINOLIN 4 YLAMINO)PROPYL] 2 (THIEN 2 YL)THIAZOLIDIN 4 ONE;
3 [3 [(7 CHLOROQUINOLIN 4 YL)AMINO]PROPYL] 2 (4 HYDROXY 3 METHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [3 [(7 CHLOROQUINOLIN 4 YL)AMINO]PROPYL] 2 PHENYLTHIAZOLIDIN 4 ONE;
3 [4 (7 CHLOROQUINOLIN 4 YLAMINO)BUTYL] 2 (3,4 DIMETHOXYPHENYL)THIAZOLIDIN 4 ONE;
3 [4 (7 CHLOROQUINOLIN 4 YLAMINO)BUTYL] 2 (FURAN 2 YL)THIAZOLIDIN 4 ONE;
3 [4 (7 CHLOROQUINOLIN 4 YLAMINO)BUTYL] 2 (THIEN 2 YL)THIAZOLIDIN 4 ONE;
3 [4 [(7 CHLOROQUINOLIN 4 YL)AMINO]BUTYL] 2 (4 HYDROXY 3 METHOXYPHENYL)THIAZOLIDIN 4 ONE;
7 CHLORO N (1 PHENYLETHYL)QUINOLIN 4 AMINE;
7 CHLORO N [(4 METHOXYPHENYL)METHYL]QUINOLIN 4 AMINE;
ANTIMALARIAL AGENT;
CHLOROQUINE;
HEMATIN;
N BENZYL 7 CHLORQUINOLIN 4 AMINE;
N1 (7 CHLOROQUINOLIN 4 YL)BUTANE 1,4 DIAMINE;
N1 (7 CHLOROQUINOLIN 4 YL)ETHANE 1,2 DIAMINE;
N1 (7 CHLOROQUINOLIN 4 YL)PROPANE 1,3 DIAMINE;
THIAZOLE DERIVATIVE;
THIAZOLIDINONE DERIVATIVE;
UNCLASSIFIED DRUG;
ANIMAL CELL;
ANTIMALARIAL ACTIVITY;
ARTICLE;
CARBON NUCLEAR MAGNETIC RESONANCE;
CONTROLLED STUDY;
CRYSTALLIZATION;
CYTOTOXICITY;
DRUG ABSORPTION;
DRUG DISTRIBUTION;
DRUG POTENCY;
DRUG SELECTIVITY;
DRUG STRUCTURE;
DRUG SYNTHESIS;
HUMAN;
HUMAN CELL;
HYBRIDIZATION;
LIPOPHILICITY;
LIVER CELL;
LIVER TOXICITY;
MELTING POINT;
NONHUMAN;
PROTON NUCLEAR MAGNETIC RESONANCE;
STRUCTURE ACTIVITY RELATION;
THIN LAYER CHROMATOGRAPHY;
ANIMALS;
ANTIMALARIALS;
CELL LINE;
CELL SURVIVAL;
CHLOROQUINE;
DRUG RESISTANCE, MULTIPLE;
HEP G2 CELLS;
HUMANS;
MALARIA, FALCIPARUM;
MICE;
PLASMODIUM FALCIPARUM;
THIAZOLIDINES;
PLASMODIUM BERGHEI;
PLASMODIUM FALCIPARUM;
|
EID: 79960565312
PISSN: 09680896
EISSN: 14643391
Source Type: Journal
DOI: 10.1016/j.bmc.2011.06.025 Document Type: Article |
Times cited : (73)
|
References (22)
|